Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells.
TGFbeta exerts a potent tumor-suppressive effect in the human colon carcinoma CBS and Moser cells. However, TGFbeta can also function as a tumor promoter. The mechanisms underlying the tumor promoting effect of TGFbeta are not understood. Both the CBS and Moser cells were found to express mutant (truncated) APC. Expression of this form of APC did not interfere with the tumor-suppressive function of TGFbeta. However, when APC expression was knocked down in these cells, TGFbeta function switched from that of tumor suppression to that of tumor promotion. TGFbeta stimulated cellular invasion and anchorage-independent growth in APC knocked-down cells. Knocking down APC expression abrogated the ability of TGFbeta to induce the expression of the tumor suppressor E-cadherin and the cyclin dependent kinase inhibitor p21/Waf1. TGFbeta now stimulated the constitutive TCF transcriptional activation activity associated with the beta-catenin/Wnt pathway in the APC knocked-down cells. Thus, the level of APC expression determined the type of TGFbeta function in these human colon carcinoma cells.
Wang
Hongmei
H
Department of Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine and SimmonsCooper Cancer Institute, Springfield, IL 62794-9677, United States.
Promkan
Moltira
M
Liu
Guangming
G
Chakrabarty
Subhas
S
D001483:Base Sequence; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000473:pathology / Q000503:physiopathology*; D055785:Gene Knockdown Techniques; D017491:Genes, APC; D006801:Humans; D012313:RNA / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015533:Transcriptional Activation; D016212:Transforming Growth Factor beta / Q000502:physiology*
D016212:Transforming Growth Factor beta; D012313:RNA
Cancer Res. 2006 Aug 15;66(16):8007-16
16912176
Curr Opin Oncol. 1996 Jan;8(1):49-53
8868100
Int J Cancer. 1990 Sep 15;46(3):493-9
1697568
Cancer Res. 2003 Jun 15;63(12):3340-6
12810668
J Cell Physiol. 2001 May;187(2):188-95
11267998
Cancer Res. 2004 Oct 15;64(20):7596-603
15492287
Lab Invest. 1998 Apr;78(4):413-21
9564886
Cancer Lett. 2008 Jun 18;264(2):281-7
18367323
Cell. 1992 Jun 26;69(7):1067-70
1319842
Int J Cancer. 1994 Jun 1;57(5):742-6
8194884
Cancer Res. 2005 Jan 15;65(2):493-8
15695391
EMBO J. 2002 Jul 15;21(14):3749-59
12110587
Cancer Metastasis Rev. 1984;3(3):177-91
6437669
Cancer Res. 2003 Apr 1;63(7):1568-75
12670906
Science. 1995 Jun 2;268(5215):1336-8
7761852
Nature. 1996 Oct 31;383(6603):832-6
8893010
Science. 1997 Mar 21;275(5307):1787-90
9065402
Cancer Res. 1989 Apr 15;49(8):2112-7
2539253
Int J Cancer. 1992 Apr 1;50(6):968-73
1555895
Oncogene. 2004 Jul 15;23(32):5558-61
15133493
J Cell Sci. 2004 Jan 26;117(Pt 3):427-39
14679305
Cancer Res. 2003 Jan 1;63(1):67-71
12517779
Cancer Res. 2006 Oct 1;66(19):9583-90
17018615
Nat Rev Cancer. 2001 Oct;1(1):55-67
11900252
Cancer Res. 2004 Jul 1;64(13):4405-10
15231647
J Biol Chem. 2000 Nov 24;275(47):36803-10
10969078
Cancer Lett. 1998 Dec 11;134(1):53-60
10381130
Cancer Res. 2004 Dec 15;64(24):9002-11
15604265